Jefferies, Goldman Sachs: Advisory on $627M GTCR Acquisition Explained
Jefferies and Goldman Sachs are advising on GTCR’s $627 million acquisition of Surmodics.
Jefferies and Goldman Sachs are advising on GTCR’s $627 million acquisition of Surmodics.